An expert review of data from 79 real-world studies showed that AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]) and the available mRNA COVID-19 vaccines provide equally effective protection against hospitalisation and death from COVID-19 following two doses.1